{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:29:37Z","timestamp":1791289777075,"version":"4.3.0"},"reference-count":134,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Assistance Publique-H\u00f4pitaux de Paris","award":["AOM05130\/P051065"],"award-info":[{"award-number":["AOM05130\/P051065"]}]},{"name":"Assistance Publique-H\u00f4pitaux de Paris","award":["AOM08198"],"award-info":[{"award-number":["AOM08198"]}]},{"name":"AIRG France"},{"DOI":"10.13039\/501100001677","name":"INSERM","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.jim.2010.12.020","type":"journal-article","created":{"date-parts":[[2011,1,7]],"date-time":"2011-01-07T09:14:25Z","timestamp":1294391665000},"page":"8-26","source":"Crossref","is-referenced-by-count":140,"title":["Alternative complement pathway assessment in patients with atypical HUS"],"prefix":"10.1016","volume":"365","author":[{"given":"Lubka T.","family":"Roumenina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Loirat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Agnes","family":"Dragon-Durey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Halbwachs-Mecarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Sautes-Fridman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"Fremeaux-Bacchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jim.2010.12.020_bb0005","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1182\/blood-2009-05-223834","article-title":"Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome","volume":"114","author":"Abarrategui-Garrido","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jim.2010.12.020_bb0010","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature05258","article-title":"The structure of complement C3b provides insights into complement activation and regulation","volume":"444","author":"Abdul Ajees","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jim.2010.12.020_bb0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0300-483X(02)00590-5","article-title":"Nickel and cobalt activate complement factor C3 faster than magnesium","volume":"185","author":"Acevedo","year":"2003","journal-title":"Toxicology"},{"key":"10.1016\/j.jim.2010.12.020_bb0020","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00467-008-0964-1","article-title":"Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome","volume":"24","author":"Ariceta","year":"2009","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.jim.2010.12.020_bb0025","doi-asserted-by":"crossref","first-page":"25168","DOI":"10.1074\/jbc.272.40.25168","article-title":"Human factor H deficiency. Mutations in framework cysteine residues and block in H protein secretion and intracellular catabolism","volume":"272","author":"Ault","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jim.2010.12.020_bb0030","doi-asserted-by":"crossref","first-page":"5928","DOI":"10.4049\/jimmunol.0901826","article-title":"Targeted inhibition of the complement alternative pathway with complement receptor 2 and factor H attenuates collagen antibody-induced arthritis in mice","volume":"183","author":"Banda","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.jim.2010.12.020_bb0035","doi-asserted-by":"crossref","first-page":"6298","DOI":"10.4049\/jimmunol.168.12.6298","article-title":"Role of membrane cofactor protein (CD46) in regulation of C4b and C3b deposited on cells","volume":"168","author":"Barilla-LaBarca","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.jim.2010.12.020_bb0040","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/j.molimm.2010.03.007","article-title":"Both domain 19 and domain 20 of factor H are involved in binding to complement C3b and C3d","volume":"47","author":"Bhattacharjee","year":"2010","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jim.2010.12.020_bb0045","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/ki.2009.472","article-title":"Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome","volume":"77","author":"Bienaime","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.jim.2010.12.020_bb0050","doi-asserted-by":"crossref","first-page":"6385","DOI":"10.4049\/jimmunol.180.9.6385","article-title":"A novel non-synonymous polymorphism (p.Arg240His) in C4b-binding protein is associated with atypical hemolytic uremic syndrome and leads to impaired alternative pathway cofactor activity","volume":"180","author":"Blom","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.jim.2010.12.020_bb0055","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/462970a","article-title":"Fraud rocks protein community","volume":"462","author":"Borrell","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jim.2010.12.020_bb0060","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.intimp.2007.08.006","article-title":"Endothelial cells are a target of both complement and kinin system","volume":"8","author":"Bossi","year":"2008","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jim.2010.12.020_bb0065","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1016\/j.molimm.2009.04.029","article-title":"Complement in human diseases: lessons from complement deficiencies","volume":"46","author":"Botto","year":"2009","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jim.2010.12.020_bb0070","doi-asserted-by":"crossref","unstructured":"Buttner-Mainik, A., Parsons, J., Jerome, H., Hartmann, A., Lamer, S., Schaaf, A., Schlosser, A., Zipfel, P.F., Reski, R., Decker, E.L., in press. Production of biologically active recombinant human factor H in Physcomitrella. Plant Biotechnol. J.","DOI":"10.1111\/j.1467-7652.2010.00552.x"},{"key":"10.1016\/j.jim.2010.12.020_bb0075","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1093\/hmg\/ddg363","article-title":"Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease","volume":"12","author":"Caprioli","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jim.2010.12.020_bb0080","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1182\/blood-2005-10-007252","article-title":"Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome","volume":"108","author":"Caprioli","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jim.2010.12.020_bb0085","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1111\/j.1600-6143.2009.02817.x","article-title":"Safety and long-term efficacy of eculizumab in a renal transplant patient with recurrent atypical hemolytic\u2013uremic syndrome","volume":"9","author":"Chatelet","year":"2009","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.jim.2010.12.020_bb0090","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1053\/j.ajkd.2009.08.011","article-title":"Maintenance of kidney function following treatment with eculizumab and discontinuation of plasma exchange after a third kidney transplant for atypical hemolytic uremic syndrome associated with a CFH mutation","volume":"55","author":"Davin","year":"2010","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.jim.2010.12.020_bb0095","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa0810739","article-title":"Thrombomodulin mutations in atypical hemolytic\u2013uremic syndrome","volume":"361","author":"Delvaeye","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jim.2010.12.020_bb0100","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/01.ASN.0000115702.28859.A7","article-title":"Heterozygous and homozygous factor h deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 cases","volume":"15","author":"Dragon-Durey","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jim.2010.12.020_bb0105","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1681\/ASN.2004050380","article-title":"Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome","volume":"16","author":"Dragon-Durey","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jim.2010.12.020_bb0110","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/jmg.2008.064766","article-title":"The high frequency of complement factor H related CFHR1 gene deletion is restricted to specific subgroups of patients with atypical haemolytic uraemic syndrome","volume":"46","author":"Dragon-Durey","year":"2009","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.jim.2010.12.020_bb0115","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2010030315","article-title":"Clinical features of anti-FH autoantibodies-associated hemolytic uremic syndrome","volume":"21","author":"Dragon-Durey","year":"2010","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.jim.2010.12.020_bb0120","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1681\/ASN.2009070706","article-title":"Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations","volume":"21","author":"Fakhouri","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jim.2010.12.020_bb0125","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1182\/blood-2007-04-084533","article-title":"Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome","volume":"111","author":"Fang","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jim.2010.12.020_bb0130","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1084\/jem.142.4.856","article-title":"Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase","volume":"142","author":"Fearon","year":"1975","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jim.2010.12.020_bb0135","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1182\/blood-2007-04-083170","article-title":"Factor H mediated cell surface protection from complement is critical for the survival of PNH erythrocytes","volume":"110","author":"Ferreira","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jim.2010.12.020_bb0140","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.4049\/jimmunol.0804031","article-title":"The binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome","volume":"182","author":"Ferreira","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.jim.2010.12.020_bb0145","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/08916930600739712","article-title":"Cross-talk between the complement system and endothelial cells in physiologic conditions and in vascular diseases","volume":"39","author":"Fischetti","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jim.2010.12.020_bb0150","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1136\/jmg.2004.019083","article-title":"Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome","volume":"41","author":"Fremeaux-Bacchi","year":"2004","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.jim.2010.12.020_bb0155","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/j.ajkd.2006.10.022","article-title":"Unusual clinical severity of complement membrane cofactor protein-associated hemolytic\u2013uremic syndrome and uniparental isodisomy","volume":"49","author":"Fremeaux-Bacchi","year":"2007","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.jim.2010.12.020_bb0160","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1182\/blood-2008-01-133702","article-title":"Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome","volume":"112","author":"Fremeaux-Bacchi","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jim.2010.12.020_bb0165","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0161-5890(99)00101-7","article-title":"FHL-1\/reconectin and factor H: two human complement regulators which are encoded by the same gene are differently expressed and regulated","volume":"36","author":"Friese","year":"1999","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jim.2010.12.020_bb0170","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1073\/pnas.0603420103","article-title":"Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome","volume":"104","author":"Goicoechea de Jorge","year":"2007","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.jim.2010.12.020_bb0175","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1056\/NEJMc0809959","article-title":"Eculizumab for congenital atypical hemolytic\u2013uremic syndrome","volume":"360","author":"Gruppo","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jim.2010.12.020_bb0180","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1167\/iovs.07-1523","article-title":"Measurement of factor H variants in plasma using variant-specific monoclonal antibodies: application to assessing risk of age-related macular degeneration","volume":"49","author":"Hakobyan","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jim.2010.12.020_bb0185","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/ki.2010.275","article-title":"Variant-specific quantification of factor H in plasma identifies null alleles associated with atypical hemolytic uremic syndrome","volume":"78","author":"Hakobyan","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.jim.2010.12.020_bb0190","doi-asserted-by":"crossref","first-page":"9053","DOI":"10.1016\/S0021-9258(18)81901-9","article-title":"Complement proteins C5b-9 induce secretion of high molecular weight multimers of endothelial von Willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface","volume":"264","author":"Hattori","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jim.2010.12.020_bb0195","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/humu.9408","article-title":"De novo gene conversion in the RCA gene cluster (1q32) causes mutations in complement factor H associated with atypical hemolytic uremic syndrome","volume":"27","author":"Heinen","year":"2006","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.jim.2010.12.020_bb0200","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1182\/blood-2009-02-205641","article-title":"Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation","volume":"114","author":"Heinen","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jim.2010.12.020_bb0205","doi-asserted-by":"crossref","first-page":"6935","DOI":"10.4049\/jimmunol.169.12.6935","article-title":"Complement C3b\/C3d and cell surface polyanions are recognized by overlapping binding sites on the most carboxyl-terminal domain of complement factor H","volume":"169","author":"Hellwage","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.jim.2010.12.020_bb0210","doi-asserted-by":"crossref","first-page":"18960","DOI":"10.1074\/jbc.M609636200","article-title":"Structure shows that a glycosaminoglycan and protein recognition site in factor H is perturbed by age-related macular degeneration-linked single nucleotide polymorphism","volume":"282","author":"Herbert","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jim.2010.12.020_bb0215","doi-asserted-by":"crossref","first-page":"9475","DOI":"10.1074\/jbc.M709587200","article-title":"Structure of the N-terminal region of complement factor H and conformational implications of disease-linked sequence variations","volume":"283","author":"Hocking","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jim.2010.12.020_bb0220","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1074\/jbc.M508928200","article-title":"The role of properdin in the assembly of the alternative pathway C3 convertases of complement","volume":"281","author":"Hourcade","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jim.2010.12.020_bb0225","doi-asserted-by":"crossref","first-page":"19716","DOI":"10.1074\/jbc.270.34.19716","article-title":"Analysis of the short consensus repeats of human complement factor B by site-directed mutagenesis","volume":"270","author":"Hourcade","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jim.2010.12.020_bb0230","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.4049\/jimmunol.162.5.2906","article-title":"Mutations of the type A domain of complement factor B that promote high-affinity C3b-binding","volume":"162","author":"Hourcade","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.jim.2010.12.020_bb0235","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nature05172","article-title":"Structure of C3b reveals conformational changes that underlie complement activity","volume":"444","author":"Janssen","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jim.2010.12.020_bb0240","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1038\/nature06102","article-title":"Crystallography: crystallographic evidence for deviating C3b structure","volume":"448","author":"Janssen","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jim.2010.12.020_bb0245","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.molimm.2009.12.001","article-title":"Impact of compound heterozygous complement factor H mutations on development of atypical hemolytic uremic syndrome-A pedigree revisited","volume":"47","author":"Johnson","year":"2010","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jim.2010.12.020_bb0250","doi-asserted-by":"crossref","first-page":"27657","DOI":"10.1074\/jbc.M002903200","article-title":"Each of the three binding sites on complement factor H interacts with a distinct site on C3b","volume":"275","author":"Jokiranta","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jim.2010.12.020_bb0255","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S1567-5769(00)00042-4","article-title":"Complement C3b interactions studied with surface plasmon resonance technique","volume":"1","author":"Jokiranta","year":"2001","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jim.2010.12.020_bb0260","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0002-9440(10)61205-9","article-title":"Binding of complement factor H to endothelial cells is mediated by the carboxy-terminal glycosaminoglycan binding site","volume":"167","author":"Jokiranta","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jim.2010.12.020_bb0265","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1038\/sj.emboj.7601052","article-title":"Structure of complement factor H carboxyl-terminus reveals molecular basis of atypical haemolytic uremic syndrome","volume":"25","author":"Jokiranta","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.jim.2010.12.020_bb0270","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.it.2008.04.008","article-title":"Factor H family proteins and human diseases","volume":"29","author":"Jozsi","year":"2008","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jim.2010.12.020_bb0275","first-page":"251","article-title":"Attachment of the soluble complement regulator factor H to cell and tissue surfaces: relevance for pathology","volume":"19","author":"Jozsi","year":"2004","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.jim.2010.12.020_bb0280","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1681\/ASN.2005080868","article-title":"Factor H and atypical hemolytic uremic syndrome: mutations in the C-terminus cause structural changes and defective recognition functions","volume":"17","author":"Jozsi","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jim.2010.12.020_bb0285","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1182\/blood-2007-02-071472","article-title":"Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome","volume":"110","author":"Jozsi","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jim.2010.12.020_bb0290","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1182\/blood-2007-09-109876","article-title":"Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1\/CFHR3 deficiency","volume":"111","author":"Jozsi","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jim.2010.12.020_bb0295","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1681\/ASN.2005010103","article-title":"Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome","volume":"16","author":"Kavanagh","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jim.2010.12.020_bb0300","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1016\/j.molimm.2007.01.036","article-title":"The decay accelerating factor mutation I197V found in hemolytic uraemic syndrome does not impair complement regulation","volume":"44","author":"Kavanagh","year":"2007","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jim.2010.12.020_bb0305","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1055\/s-0030-1262887","article-title":"Transplantation in atypical hemolytic uremic syndrome","volume":"36","author":"Kavanagh","year":"2010","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.jim.2010.12.020_bb0310","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4049\/jimmunol.122.1.75","article-title":"Human alternative complement pathway: membrane-associated sialic acid regulates the competition between B and beta1 H for cell-bound C3b","volume":"122","author":"Kazatchkine","year":"1979","journal-title":"J. Immunol."},{"key":"10.1016\/j.jim.2010.12.020_bb0315","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1016\/j.molimm.2008.06.034","article-title":"Properdin: new roles in pattern recognition and target clearance","volume":"45","author":"Kemper","year":"2008","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jim.2010.12.020_bb0320","doi-asserted-by":"crossref","first-page":"9023","DOI":"10.1073\/pnas.0801015105","article-title":"The complement protein properdin binds apoptotic T cells and promotes complement activation and phagocytosis","volume":"105","author":"Kemper","year":"2008","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.jim.2010.12.020_bb0330","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1146\/annurev-immunol-030409-101250","article-title":"Properdin: emerging roles of a pattern-recognition molecule","volume":"28","author":"Kemper","year":"2010","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jim.2010.12.020_bb0335","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.4049\/jimmunol.155.3.1434","article-title":"Enhancement by the complement membrane attack complex of tumor necrosis factor-alpha-induced endothelial cell expression of E-selectin and ICAM-1","volume":"155","author":"Kilgore","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.jim.2010.12.020_bb0340","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1055\/s-0030-1262889","article-title":"New treatment options for atypical hemolytic uremic syndrome with the complement inhibitor eculizumab","volume":"36","author":"Kose","year":"2010","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.jim.2010.12.020_bb0345","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jim.2009.11.003","article-title":"Preparing serum for functional complement assays","volume":"352","author":"Lachmann","year":"2010","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2010.12.020_bb0350","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/TP.0b013e3181ccd80d","article-title":"Efficacy of eculizumab in the treatment of recurrent atypical hemolytic-uremic syndrome after renal transplantation","volume":"89","author":"Larrea","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.jim.2010.12.020_bb0355","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1111\/j.1600-6143.2008.02297.x","article-title":"Complement mutation-associated de novo thrombotic microangiopathy following kidney transplantation","volume":"8","author":"Le Quintrec","year":"2008","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.jim.2010.12.020_bb0360","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1055\/s-0030-1262886","article-title":"Atypical hemolytic uremic syndrome associated with mutations in complement regulator genes","volume":"36","author":"Le Quintrec","year":"2010","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.jim.2010.12.020_bb0365","doi-asserted-by":"crossref","first-page":"15650","DOI":"10.1074\/jbc.M900814200","article-title":"Mutations of factor H impair regulation of surface-bound C3b by three mechanisms in atypical hemolytic uremic syndrome","volume":"284","author":"Lehtinen","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jim.2010.12.020_bb0370","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.2215\/CJN.06281208","article-title":"A large family with a gain-of-function mutation of complement C3 predisposing to atypical hemolytic uremic syndrome, microhematuria, hypertension and chronic renal failure","volume":"4","author":"Lhotta","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jim.2010.12.020_bb0375","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/sj.ki.5000269","article-title":"Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II)","volume":"70","author":"Licht","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.jim.2010.12.020_bb0380","doi-asserted-by":"crossref","first-page":"37692","DOI":"10.1074\/jbc.M004650200","article-title":"Dissecting sites important for complement regulatory activity in membrane cofactor protein (MCP; CD46)","volume":"275","author":"Liszewski","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jim.2010.12.020_bb0385","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/j.molimm.2006.08.024","article-title":"Modeling how CD46 deficiency predisposes to atypical hemolytic uremic syndrome","volume":"44","author":"Liszewski","year":"2007","journal-title":"Mol. Immunol."},{"issue":"Suppl 8","key":"10.1016\/j.jim.2010.12.020_bb0390","doi-asserted-by":"crossref","first-page":"I22","DOI":"10.1016\/j.vaccine.2008.11.001","article-title":"Inhibiting complement activation on cells at the step of C3 cleavage","volume":"26","author":"Liszewski","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2010.12.020_bb0395","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1007\/s00467-008-0872-4","article-title":"Complement and the atypical hemolytic uremic syndrome in children","volume":"23","author":"Loirat","year":"2008","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.jim.2010.12.020_bb0400","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1055\/s-0030-1262890","article-title":"Plasmatherapy in atypical hemolytic uremic syndrome","volume":"36","author":"Loirat","year":"2010","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.jim.2010.12.020_bb0405","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.2215\/CJN.01090209","article-title":"Complement inhibitor eculizumab in atypical hemolytic uremic syndrome","volume":"4","author":"Mache","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jim.2010.12.020_bb0410","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/j.biocel.2009.04.005","article-title":"Complement component 5a (C5a)","volume":"41","author":"Manthey","year":"2009","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.jim.2010.12.020_bb0415","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1172\/JCI16651","article-title":"Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome","volume":"111","author":"Manuelian","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jim.2010.12.020_bb0420","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2249.2008.03798.x","article-title":"Lack of association between polymorphisms in C4b-binding protein and atypical haemolytic uraemic syndrome in the Spanish population","volume":"155","author":"Martinez-Barricarte","year":"2009","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jim.2010.12.020_bb0425","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jim.2008.05.011","article-title":"Enzyme-independent, orientation-selective conjugation of whole human complement C3 to protein surfaces","volume":"337","author":"Mitchell","year":"2008","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2010.12.020_bb0430","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1016\/j.molimm.2007.06.150","article-title":"Complement analysis in the 21st century","volume":"44","author":"Mollnes","year":"2007","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jim.2010.12.020_bb0435","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1016\/j.molimm.2008.01.027","article-title":"Genetic deficiency of complement factor H in a patient with age-related macular degeneration and membranoproliferative glomerulonephritis","volume":"45","author":"Montes","year":"2008","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jim.2010.12.020_bb0440","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1073\/pnas.0812584106","article-title":"Functional basis of protection against age-related macular degeneration conferred by a common polymorphism in complement factor B","volume":"106","author":"Montes","year":"2009","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.jim.2010.12.020_bb0445","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1182\/blood-2009-05-221549","article-title":"Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome","volume":"115","author":"Moore","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jim.2010.12.020_bb0450","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1136\/jmg.40.9.676","article-title":"Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries","volume":"40","author":"Neumann","year":"2003","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.jim.2010.12.020_bb0455","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.molimm.2006.10.005","article-title":"A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor I in complement regulation","volume":"44","author":"Nilsson","year":"2007","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jim.2010.12.020_bb0460","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/eji.200838702","article-title":"Genetic, molecular and functional analyses of complement factor I deficiency","volume":"39","author":"Nilsson","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jim.2010.12.020_bb0465","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/eji.200939280","article-title":"Mutations in complement factor I as found in atypical hemolytic uremic syndrome lead to either altered secretion or altered function of factor I","volume":"40","author":"Nilsson","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jim.2010.12.020_bb0470","doi-asserted-by":"crossref","first-page":"6235","DOI":"10.1074\/jbc.M109.097212","article-title":"Analysis of binding sites on complement factor I that are required for its activity","volume":"285","author":"Nilsson","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jim.2010.12.020_bb0475","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJMra0902814","article-title":"Atypical hemolytic\u2013uremic syndrome","volume":"361","author":"Noris","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jim.2010.12.020_bb0480","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1056\/NEJMc0808527","article-title":"Eculizumab for atypical hemolytic\u2013uremic syndrome","volume":"360","author":"Nurnberger","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jim.2010.12.020_bb0485","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1055\/s-0030-1262882","article-title":"Modern determination of complement activation","volume":"36","author":"Oppermann","year":"2010","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.jim.2010.12.020_bb0490","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0022-1759(90)90358-3","article-title":"Quantitation of components of the alternative pathway of complement (APC) by enzyme-linked immunosorbent assays","volume":"133","author":"Oppermann","year":"1990","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2010.12.020_bb0495","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1365-2249.2006.03071.x","article-title":"The C-terminus of complement regulator Factor H mediates target recognition: evidence for a compact conformation of the native protein","volume":"144","author":"Oppermann","year":"2006","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jim.2010.12.020_bb0500","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.molimm.2005.09.012","article-title":"Localization of the third heparin-binding site in the human complement regulator factor H1","volume":"43","author":"Ormsby","year":"2006","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jim.2010.12.020_bb0505","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1042\/bj2350723","article-title":"The C3 convertase of the alternative pathway of human complement. Enzymic properties of the bimolecular proteinase","volume":"235","author":"Pangburn","year":"1986","journal-title":"Biochem. J."},{"key":"10.1016\/j.jim.2010.12.020_bb0510","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1086\/318201","article-title":"Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome","volume":"68","author":"Perez-Caballero","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jim.2010.12.020_bb0515","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s004240000307","article-title":"The endothelial surface layer","volume":"440","author":"Pries","year":"2000","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.jim.2010.12.020_bb0520","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1084\/jem.20071069","article-title":"Structural basis for complement factor H linked age-related macular degeneration","volume":"204","author":"Prosser","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jim.2010.12.020_bb0525","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0040-8166(98)80032-3","article-title":"Effect of culture conditions on endothelial cell growth and responsiveness","volume":"30","author":"Relou","year":"1998","journal-title":"Tissue Cell"},{"key":"10.1016\/j.jim.2010.12.020_bb0530","doi-asserted-by":"crossref","first-page":"12966","DOI":"10.1073\/pnas.2135497100","article-title":"Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome","volume":"100","author":"Richards","year":"2003","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.jim.2010.12.020_bb0535","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.molimm.2006.07.004","article-title":"Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndrome","volume":"44","author":"Richards","year":"2007","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jim.2010.12.020_bb0540","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni.1923","article-title":"Complement: a key system for immune surveillance and homeostasis","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jim.2010.12.020_bb0545","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nrneph.2010.98","article-title":"Thrombotic microangiopathy: atypical HUS: current diagnostic and therapeutic approaches","volume":"6","author":"Rosales","year":"2010","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.jim.2010.12.020_bb0550","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1182\/blood-2009-01-197640","article-title":"Hyperfunctional C3 convertase leads to complement deposition on endothelial cells and contributes to atypical hemolytic uremic syndrome","volume":"114","author":"Roumenina","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jim.2010.12.020_bb0555","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1681\/ASN.2008080906","article-title":"Liver\u2013kidney transplantation to cure atypical hemolytic uremic syndrome","volume":"20","author":"Saland","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jim.2010.12.020_bb0560","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1086\/344515","article-title":"Structural and functional characterization of factor H mutations associated with atypical hemolytic uremic syndrome","volume":"71","author":"Sanchez-Corral","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jim.2010.12.020_bb0565","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.molimm.2004.01.003","article-title":"Functional analysis in serum from atypical Hemolytic Uremic Syndrome patients reveals impaired protection of host cells associated with mutations in factor H","volume":"41","author":"Sanchez-Corral","year":"2004","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jim.2010.12.020_bb0570","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1038\/sj.ki.5000277","article-title":"Conditionally immortalized human glomerular endothelial cells expressing fenestrations in response to VEGF","volume":"69","author":"Satchell","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.jim.2010.12.020_bb0575","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1055\/s-2006-939772","article-title":"A user's guide to the interactive Web database of factor H-associated hemolytic uremic syndrome","volume":"32","author":"Saunders","year":"2006","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.jim.2010.12.020_bb0580","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/humu.20268","article-title":"An interactive web database of factor H-associated hemolytic uremic syndrome mutations: insights into the structural consequences of disease-associated mutations","volume":"27","author":"Saunders","year":"2006","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.jim.2010.12.020_bb0585","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.4049\/jimmunol.181.4.2610","article-title":"A new map of glycosaminoglycan and C3b binding sites on factor H","volume":"181","author":"Schmidt","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.jim.2010.12.020_bb0590","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1681\/ASN.2006080811","article-title":"Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome","volume":"18","author":"Sellier-Leclerc","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"issue":"Suppl 8","key":"10.1016\/j.jim.2010.12.020_bb0595","doi-asserted-by":"crossref","first-page":"I9","DOI":"10.1016\/j.vaccine.2008.11.021","article-title":"Complement factor H related proteins in immune diseases","volume":"26","author":"Skerka","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2010.12.020_bb0600","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.4049\/jimmunol.179.4.2600","article-title":"Properdin can initiate complement activation by binding specific target surfaces and providing a platform for de novo convertase assembly","volume":"179","author":"Spitzer","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.jim.2010.12.020_bb0605","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2141.2009.07916.x","article-title":"Clinical practice guidelines for the management of atypical haemolytic uraemic syndrome in the United Kingdom","volume":"148","author":"Taylor","year":"2010","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jim.2010.12.020_bb0610","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1084\/jem.185.9.1619","article-title":"The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity","volume":"185","author":"Tedesco","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jim.2010.12.020_bb0615","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1073\/pnas.0810860106","article-title":"3D structure of the C3bB complex provides insights into the activation and regulation of the complement alternative pathway convertase","volume":"106","author":"Torreira","year":"2009","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.jim.2010.12.020_bb0620","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1093\/hmg\/ddp289","article-title":"The disease-protective complement factor H allotypic variant Ile62 shows increased binding affinity for C3b and enhanced cofactor activity","volume":"18","author":"Tortajada","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jim.2010.12.020_bb0625","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/sj.ki.5000155","article-title":"Phenotypic expression of factor H mutations in patients with atypical hemolytic uremic syndrome","volume":"69","author":"Vaziri-Sani","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.jim.2010.12.020_bb0630","doi-asserted-by":"crossref","first-page":"e431","DOI":"10.1371\/journal.pmed.0030431","article-title":"Atypical haemolytic uraemic syndrome associated with a hybrid complement gene","volume":"3","author":"Venables","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.jim.2010.12.020_bb0635","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF00858956","article-title":"Inherited factor H deficiency and collagen type III glomerulopathy","volume":"9","author":"Vogt","year":"1995","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.jim.2010.12.020_bb0640","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJM200104053441406","article-title":"Complement. First of two parts","volume":"344","author":"Walport","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jim.2010.12.020_bb0645","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJM200104123441506","article-title":"Complement. Second of two parts","volume":"344","author":"Walport","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jim.2010.12.020_bb0650","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/ni.1755","article-title":"Structure of complement fragment C3b-factor H and implications for host protection by complement regulators","volume":"10","author":"Wu","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jim.2010.12.020_bb0655","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1056\/NEJMc1001060","article-title":"Prophylactic eculizumab after renal transplantation in atypical hemolytic-uremic syndrome","volume":"362","author":"Zimmerhackl","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jim.2010.12.020_bb0660","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1371\/journal.pgen.0030041","article-title":"Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome","volume":"3","author":"Zipfel","year":"2007","journal-title":"PLoS Genet."},{"issue":"Pt 10","key":"10.1016\/j.jim.2010.12.020_bb0665","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1242\/jcs.109.10.2571","article-title":"Serum albumin is a specific inhibitor of apoptosis in human endothelial cells","volume":"109","author":"Zoellner","year":"1996","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.jim.2010.12.020_bb0670","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1006\/mvre.1998.2126","article-title":"Inhibition of microvascular endothelial apoptosis in tissue explants by serum albumin","volume":"57","author":"Zoellner","year":"1999","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.jim.2010.12.020_bb0675","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrneph.2010.155","article-title":"New insights inot postrenal transplant hemolytic uremic syndrome","volume":"7","author":"Zuber","year":"2011","journal-title":"Nat Rev Nephrol."}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175911000020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175911000020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T19:37:24Z","timestamp":1685907444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175911000020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":134,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0022175911000020"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2010.12.020","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}